| Tag | Content |
|---|
EnhancerAtlas ID | HS095-30679 | Organism | Homo sapiens | Tissue/cell | HMEC | Coordinate | chr9:33835550-33836800 | | | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_09695 | chr9:33835044-33837582 | CD14 | | SE_60454 | chr9:33813146-33886308 | DHL6 |
| | | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
| | | Number: 1 | ID | Chromosome | Start | End |
| GH09I033835 | chr9 | 33835163 | 33837397 |
| Enhancer Sequence | AAACTTTATA TGTCCTTACA ATTTTTGTTT GTTTTTGAGA CAGAGTTGGC CAGGCACAGT 60
GGCTTACACC TGTAATCTGA GCACTTTGGG AGGCTGAGGT GTGTGGATCA CTTGAGCCCA 120
CGAGTTCAAG ACCAGCCTGG GTGACATAGG GAGATCCCGT TTCTACAAAA AAAAAAACAA 180
AACAGCCAGG CCTGGTGGCA CGCACCTGTA GTCCCAACTA CTCAGGAGGC TGAGGTGGGA 240
GGATCATTTG AGCCTGGGAA TTCAAGGTTA CAGTGAGCTA TGATTGCACT ACTGCACTCC 300
AGCCTGGGCA ACGGAGTGAG ACCCTTTCTC TAAAAAAGGC TTGTAGAAGA AAGTAAAGAT 360
ATGAGTTATT TTTGTACAGC TGTATAGTGT GATTTCGTTT TAAGCTAAGA AGCTAAGTGT 420
TGTTTCAAAG GTCAAAAAGT TAAAAGTTTG TATAGTATAA GAATTGTGGG CTGGGCACAG 480
TGGCTCACGC CTGTTATCCC AGCACTTTCG GGAGGGCGAG GCAGATGGAT CACCTGAGGT 540
CAGGAGTTTG AGACCAGCCC GGCCAGCATG GTGAAACCCT GTCTCTACTA AAAATATAGA 600
AAAATTAGCT GGGCGTGGTG GGAGGCGCCT ATAATCCCAG CTACTCACCT ACAATATTCA 660
GTATAGTAAC ATGCTGTACA GGTTTGAAGC CTAGGAGCAA TAGGCTATAC CATATAGCCT 720
AGATGTGTAG GAGCCTATAC CATCTAGGTA CAAGTATACC ATTTTTGTGT AAGCATGCTG 780
TATGATGTTC ACACAATGAT GAAATTGCCT AATGATGCAT TTCTCAGAAC ATATTCCTGT 840
CATTAGGCAA CATATGACTG TAATTCAGTG GTTTTTAGTC AGAATTGTGC AATCATCACC 900
ACAGTCAATT TTAGAATATT TTGCTGGGCT TGGTGGCTCA TGCCTATGAT CCCAGTACTT 960
TGGGAGGCAG AGGCACGCAG ATCATTTGAG GTCAGGAGTT TGAGAGCATC CTGGCCAACA 1020
TGGCAAAGCC CCATCTCTAC TAAAAATACA AAAAATTAGC CAGACATGGT GGCACATGCC 1080
TGTAGTCCCA GCTACTCGGG AGGCAGAGGC AGGAGAATCA CTTCAACCTG GGAGGCAGAG 1140
GATGCAGTGA GCCAAGATCA TGCCACTGTA CTCCAGCCTG GGCAACAGAG CAAGACTCTT 1200
ATCTCAAAAA AAAAAAATAT ATATATATAT ATTCTTGAGG AAGTGTGCCT 1250
|
| |
|
|
|
